Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

October 4, 2021

Study Completion Date

October 4, 2021

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Minimal questionnaire

The minimal questionnaire is a reduced version of the medical interview and it will include questions about sociodemographic information, previous diagnosis of COPD, co-morbidities and smoking habits.

OTHER

Medical interview

Medical interview includes medical history, sociodemographic and clinical information, including disease history, treatment history, smoking habits and use of biomass.

OTHER

CAT

The CAT is a questionnaire for COPD patients and is designed to measure the impact of COPD on a person's life over time.

PROCEDURE

Blood test

Blood samples will be collected at indicated time points

OTHER

anthropometric measures

Anthropologic measures will be performed.

OTHER

Oximetry

Digital pulse oximeter on the index finger after five minutes rest and before receiving bronchodilator for spirometry will be used to measure the pulse arterial oximetry. The average of three measurements at 10 second intervals will be recorded. The heart rate will be provided by the pulse oximeter.

Trial Locations (4)

18618686

GSK Investigational Site, Botucatu

86039-440

GSK Investigational Site, Londrina

90610-000

GSK Investigational Site, Porto Alegre

14801-320

GSK Investigational Site, Araraquara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03018808 - Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients | Biotech Hunter | Biotech Hunter